Skip to main content

Table 2 Demographic features, ROTEM and CAT results of both groups

From: Behçet’s disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity

Characteristics

BD patients (N = 23)

Controls (N = 33)

p-value

Age at inclusion (year)

49 ± 15

43 ± 10

0.082

Female gender (%)

78

63

0.241

 

INTEM-α (degree)

77 ± 3

74 ± 2

<0.010

ROTEM

INTEM-CFT (sec)

66 ± 15

80 ± 14

<0.010

INTEM-MCF (mm)

61 ± 4

57 ± 4

<0.010

 

Platelet contribution-MCF (%)

78 (69–79)

79 (77–81)

0.090

 

Lag-time (min)

6.7 ± 1.8

5.6 ± 1.1

0.025

CAT

Time-to-peak (min)

9.6 ± 1.9

9.0 ± 1.4

0.240

Peak height (nM)

292 ± 65

213 ± 67

<0.010

ETP (nM × min)

1543 ± 331

1286 ± 292

0.010

 

Velocity index (nM/min)

102 (83–127)

55 (42–90)

<0.010

 

Platelet count (×103/μl)

217 (189–287)

227 (199–247)

0.785

 

Erythrocyte count (×106/μl)

4.2 ± 0.4

4.3 ± 0.4

0.244

 

Fibrinogen (mg/l)

321 ± 53

280 ± 42

<0.010

TAT (ng/l)

19 (17–21)

15 (12–17)

<0.010

Other parameters

D-dimer (μg/l)

293 ± 65

270 ± 86

0.480

tPA (antigen) (ng/ml)

17.2 ± 7.2

12.4 ± 5.2

0.120

 

PAI-1 (antigen) (ng/ml)

19.9 ± 8.6

12.6 ± 6.0

0.032

 

E-selectin (μg/l)

24.2 ± 9.3

16.8 ± 8.4

0.040

 

C-reactive protein (mg/dl)

0.2 (0.1-0.5)

0.1 (0.1-0.4)

0.046

  1. Results are expressed as the mean ± SD, the median and range (25th-75th percentile) or as absolute value (%).